EUVIMEDEUVIMED entdecken
Crossref

Furo[2,3‐ d ]pyrimidines as Mackinazolinone/Isaindigotone Analogs: Synthesis, Modification, Antitumor Activity, and Molecular Docking Study

Buer Song, Lifei Nie, Khurshed Bozorov, Chao Niu, Rustamkhon Kuryazov, Haji Akber Aisa, Jiangyu Zhao

Chemistry & Biodiversity · 2023-03 · 20 (3)

DOI: 10.1002/cbdv.202201059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 09.02.2023. Verfasst von Buer Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chine…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Alkaloids. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Key R&D Program of China, Xinjiang Science and Technology Major Project, "CAM Resources Data Base" in National Basic Science Data Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The chemical transformation of the tricyclic furo[2,3‐ d ]pyrimidines was performed under isosteric and scaffold‐hopping strategies focusing on the synthesis of its arylidene and imine‐containing derivatives. Naturally‐occurring alkaloids mackinazolinone and isaindigotone were as templates of target heterocycles. Synthesized compounds evaluated for their antitumor activity on human cancer cervical HeLa, breast MCF‐7, and colon HT‐29 cell lines. Four compounds: 8c , 8e , 10b , and 10c demonstrated potency against HeLa and HT‐29 cell lines, and IC 50 values were between 7.37–13.72 μM, respectively. The molecular docking results showed that compounds 8c and 10b had good binding and high matching with the target EGFR protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAlkaloidsHumansMolecular Docking SimulationStructure-Activity RelationshipPyrimidinesDrug Screening Assays, AntitumorMolecular StructureCell Line, TumorCell ProliferationDrug DesignQuinazolinesQuinazolinones

Stichwörter der Autor:innen

EGFRantitumor activityarylidenefuro[2,3-d]pyrimidinemackinazolinone

Substanzen

Antineoplastic AgentsPyrimidinesAlkaloidsisaindigotoneQuinazolinesmackinazolinoneQuinazolinones

Autor:innen und Institutionen

  • State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Rd 40-1, Urumqi, 830011, P. R. C…
  • University of Chinese Academy of Sciences, 19 A Yuquan Rd, Beijing, 100049, P. R. China.
  • Faculty of Chemistry, Samarkand State University, University Blvd. 15, Samarkand, 140104, Uzbekistan.
  • Urgench State University, Kh. Olimjon st. 14, Urgench, 220100, Uzbekistan.

Förderung

  • National Key R&D Program of China
  • Xinjiang Science and Technology Major Project
  • "CAM Resources Data Base" in National Basic Science Data Center
  • National Key Research and Development Program of China

Zitieren

APA

Song, B., Nie, L., Bozorov, K., Niu, C., Kuryazov, R., Akber Aisa, H., & Zhao, J. (2023). Furo[2,3‐ d ]pyrimidines as Mackinazolinone/Isaindigotone Analogs: Synthesis, Modification, Antitumor Activity, and Molecular Docking Study. Chemistry & Biodiversity, 20(3). https://doi.org/10.1002/cbdv.202201059

Vancouver

Song B, Nie L, Bozorov K, Niu C, Kuryazov R, Akber Aisa H, et al. Furo[2,3‐ d ]pyrimidines as Mackinazolinone/Isaindigotone Analogs: Synthesis, Modification, Antitumor Activity, and Molecular Docking Study. Chemistry & Biodiversity. 2023;20(3). doi:10.1002/cbdv.202201059

BibTeX
@article{Song2023,
  author = {Song, Buer and Nie, Lifei and Bozorov, Khurshed and Niu, Chao and Kuryazov, Rustamkhon and Akber Aisa, Haji and Zhao, Jiangyu},
  title = {Furo[2,3‐ d ]pyrimidines as Mackinazolinone/Isaindigotone Analogs: Synthesis, Modification, Antitumor Activity, and Molecular Docking Study},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  volume = {20},
  number = {3},
  doi = {10.1002/cbdv.202201059}
}
Kostenlos starten →